Understanding the Genetic Landscape of Cancer Drug Resistance

Understanding the Genetic Landscape of Cancer Drug Resistance The recent advancements in genetic mapping and editing technologies have opened new avenues in the fight against cancer, particularly in understanding and combating drug resistance. A groundbreaking study conducted by researchers from the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has shed light […]